Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Serosurveillance of varicella and hepatitis B infection after reported cases in medical students and the relationship between past varicella disease history and immunity status.

Suwanpakdee D, Laohapand C, Moolasart V, Lomtong P, Krairojananan N, Srisawat P, Watanaveeradej V.

J Med Assoc Thai. 2012 May;95 Suppl 5:S80-5.

PMID:
22934450
2.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
3.

[Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].

Yoshida N, Tsumura N, Toyomasu K, Sagawa K.

Sangyo Eiseigaku Zasshi. 2007 Jan;49(1):21-6. Japanese.

4.

Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease.

Trevisan A, Frasson C, Morandin M, Beggio M, Bruno A, Davanzo E, Di Marco L, Simioni L, Amato G.

Infect Control Hosp Epidemiol. 2007 May;28(5):564-9. Epub 2007 Apr 12.

PMID:
17464916
5.

[Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].

Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.

An Esp Pediatr. 1999 May;50(5):459-62. Spanish.

PMID:
10394183
6.

Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?

Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.

Am J Infect Control. 2006 Nov;34(9):583-7.

PMID:
17097453
7.

Seroprevalence of measles, mumps, rubella, varicella-zoster and hepatitis A-C in Emirati medical students.

Sheek-Hussein M, Hashmey R, Alsuwaidi AR, Al Maskari F, Amiri L, Souid AK.

BMC Public Health. 2012 Dec 5;12:1047. doi: 10.1186/1471-2458-12-1047.

8.

Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

Llenas-García J, Rubio R, Hernando A, Arrazola P, Pulido F.

AIDS Care. 2013 Aug;25(8):980-9. doi: 10.1080/09540121.2012.748881. Epub 2012 Dec 17.

PMID:
23244745
9.
10.

[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].

Buxbaum S, Doerr HW, Allwinn R.

Dtsch Med Wochenschr. 2001 Nov 16;126(46):1289-93. German.

PMID:
11709730
11.

Seroprevalence and immunization history of selected vaccine preventable diseases in medical students.

Baer G, Bonhoeffer J, Schaad UB, Heininger U.

Vaccine. 2005 Mar 14;23(16):2016-20.

PMID:
15734076
12.

High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Socan M, Berginc N.

Wien Klin Wochenschr. 2008;120(13-14):422-6. doi: 10.1007/s00508-008-1005-6.

PMID:
18726668
13.

Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.

Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M.

Infect Control Hosp Epidemiol. 2006 Nov;27(11):1178-83. Epub 2006 Oct 17.

PMID:
17080374
14.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
15.

Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia.

Abbas M, Atwa M, Emara A.

J Egypt Public Health Assoc. 2007;82(3-4):283-97.

PMID:
18410713
16.

Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.

Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K.

Am J Infect Control. 2003 May;31(3):157-62.

PMID:
12734521
17.

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.

Shinefield HR, Black SB, Staehle BO, Matthews H, Adelman T, Ensor K, Li S, Chan I, Heyse J, Waters M, Chan CY, Vessey SJ, Kaplan KM, Kuter BJ; Kaiser Permanente Medical Team for Varivax.

Pediatr Infect Dis J. 2002 Jun;21(6):555-61.

PMID:
12182381
18.

Combination measles, mumps, rubella and varicella vaccine.

Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.

Pediatrics. 1986 Oct;78(4 Pt 2):742-7.

PMID:
3763291
19.

Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.

Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.

Vaccine. 2013 Aug 12;31(36):3683-7. doi: 10.1016/j.vaccine.2013.05.102. Epub 2013 Jun 13.

PMID:
23770334
20.

Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey.

Kader Ç, Erbay A, Akça NK, Polat MF, Polat S.

Am J Infect Control. 2016 Jan 1;44(1):e5-7. doi: 10.1016/j.ajic.2015.08.021. Epub 2015 Oct 9.

PMID:
26442461

Supplemental Content

Support Center